NMCIX
Price
$24.96
Change
+$0.10 (+0.40%)
Updated
Jun 2 closing price
Net Assets
590.18M
TRQZX
Price
$100.78
Change
-$0.22 (-0.22%)
Updated
Jun 2 closing price
Net Assets
23.23B
Interact to see
Advertisement

NMCIX vs TRQZX

Header iconNMCIX vs TRQZX Comparison
Open Charts NMCIX vs TRQZXBanner chart's image
NMCIX vs TRQZX Comparison Chart in %
View a ticker or compare two or three
VS
NMCIX vs. TRQZX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NMCIX is a Buy and TRQZX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRQZX has more cash in the bank: 23.2B vs. NMCIX (590M). TRQZX pays higher dividends than NMCIX: TRQZX (0.72) vs NMCIX (0.00). NMCIX was incepted earlier than TRQZX: NMCIX (28 years) vs TRQZX (6 years). NMCIX (0.96) is less costly to investors than TRQZX (0.61). NMCIX is a more actively managed with annual turnover of: 87.00 vs. TRQZX (31.50). TRQZX has a lower initial minimum investment than NMCIX: TRQZX (0) vs NMCIX (250000). TRQZX annual gain was more profitable for investors over the last year : 3.47 vs. NMCIX (-4.20). TRQZX return over 5 years is better than : -13.33 vs. NMCIX (-14.69).
NMCIXTRQZXNMCIX / TRQZX
Total Expense Ratio0.930.00-
Annual Report Gross Expense Ratio0.960.61157%
Fund Existence28 years6 years-
Gain YTD7.6662.726281%
Front LoadN/AN/A-
Min. Initial Investment2500000-
Min. Initial Investment IRAN/AN/A-
Net Assets590M23.2B3%
Annual Yield % from dividends0.000.72-
Returns for 1 year-4.203.47-121%
Returns for 3 years14.936.62225%
Returns for 5 years-14.69-13.33110%
Returns for 10 years3.11N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INMB1.420.03
+2.16%
INmune Bio
MRK115.650.48
+0.42%
Merck & Co
POLE10.740.01
+0.05%
Andretti Acquisition Corp. II
QMMM119.40N/A
N/A
QMMM Holdings Ltd
VIR8.74-0.29
-3.21%
Vir Biotechnology